IL1B and Obesity: Supporting these findings in the context of obesity and diabetes, Osborn and colleagues observed significantly reduced HbA1c levels when they treated mice suffering from T2D with anti-IL-1β antibodies, which indicates a beneficial effect on glucose tolerance and/or insulin resistance [52].